| Dec 18 | Dec 17 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | $ 0.00 | $ 0.00 |
| Gross Profit | - | - |
| Operating Income | $ -4.30M | $ -4.55M |
| EBITDA | $ -3.56M | $ -4.55M |
| Net Income | $ -10.26M | $ -4.56M |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ 3.46M | $ 970.54K |
| Total Assets | $ 3.55M | $ 1.06M |
| Total Debt | $ 0.00 | $ 0.00 |
| Net Debt | $ -3.46M | $ -970.54K |
| Total Liabilities | $ 12.99M | $ 270.49K |
| Stockholders' Equity | $ -9.44M | $ 790.60K |
| Cash Flow | ||
| Free Cash Flow | $ -2.53M | $ -1.20M |
| Operating Cash Flow | $ -2.50M | $ -1.19M |
| Investing Cash Flow | $ -28.00K | $ -9.51K |
| Financing Cash Flow | $ 5.02M | $ 1.69M |
OWC Pharmaceutical Research Corp (DE:0OW)
STUTTGART:0OW
